This trial is testing a new cancer drug to see if it is safe for people with advanced pancreatic cancer.
1 Primary · 9 Secondary · Reporting Duration: 3 Years
Experimental Treatment
58 Total Participants · 3 Treatment Groups
Primary Treatment: ProAgio · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: